Welcome to our dedicated page for FendX Technologies news (Ticker: FDXTD), a resource for investors and traders seeking the latest updates and insights on FendX Technologies stock.
News related to FendX Technologies Inc. (FDXTD) centers on its activities as a surface protection company developing technology-based solutions aimed at reducing the spread of harmful pathogens. Company announcements describe work on specialized coatings, films and cleaning products positioned around hygiene and pathogen reduction in both everyday and medical environments.
One area highlighted in FendX news is the development of medical catheter coatings. The company has reported a provisional patent application titled "Lubricated Dilated Medical Catheters and Cannula and Uses Thereof" filed with the United States Patent and Trademark Office, with FendX listed as the assignee. Related disclosures describe catheter coatings designed to create low friction surfaces that enhance patient comfort during insertion and reduce microbial growth on catheter surfaces, which is considered an important factor in infection risk.
FendX news releases also discuss its broader pipeline, including REPELWRAP3 film, a protective surface coating with repelling properties that significantly reduce adhesion and transmission of pathogens on high-touch surfaces, and a spray-based coating with similar functionality. In addition, the company reports progress on an eco-friendly, smart sponge intended to provide effective cleaning while minimizing environmental impact, supported by an exclusive supply agreement and related intellectual property rights.
Visitors to this FDXTD news page can review company-issued updates on patent filings, product development milestones and descriptions of its surface protection technologies. These disclosures provide context on how FendX characterizes its work in specialty coatings, films and cleaning products focused on pathogen reduction.
FendX Technologies (OTCQB:FDXTD) has filed a provisional patent application with the USPTO for a novel medical catheter coating technology. The patent, titled "Lubricated Dilated Medical Catheters and Cannula and Uses Thereof," focuses on a specialized coating that provides dual benefits: enhanced patient comfort through reduced friction during insertion and reduced microbial growth on catheter surfaces.
The innovation, developed by Drs. Carolyn Myers, Tohid Didar, Martin Stark, and Leyla Soleymani, represents an advancement in FendX's portfolio of hygiene-related technologies, specifically targeting infection risk reduction in medical devices.